biomedicina slovenica


"Homocysteine" : 90

  1. Taler-Verčič Ajda; Goličnik Marko; Bavec Aljoša
    The structure and function of paraoxonase-1 and its comparison to paraoxonase-2 and -3
    2020
  2. Vidmar Maša; Trontelj Jurij; Geršak Ksenija; Mlinarič-Raščan Irena; Šmid Alenka
    Simultaneous quantification of intracellular concentrations of clinically important metabolites of folate-homocysteine cycle by LC-MS/MS
    2020
  3. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of polyoxyethylene (20) sorbitan monooleate as a feed additive for all animal species
    2016
  4. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of Probiomix B (Lactobacillus plantarum KKP/593/p and Lactobacillus rhamnosus KKP 825) as a feed additive for chickens for fattening
    2016
  5. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of iron compounds (E1) as feed additives for all animal species: ferrous carbonate; ferric chloride, hexahydrate; ferrous fumarate; ferrous sulphate, heptahydrate; ferrous sulphate, monohydrate; ferrous chelate of amino acids, hydrate; ferrous chelate of glycine, hydrate, based on a dossier submitted by FEFANA asbl
    2016
  6. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of RONOZYME
    2016
  7. Aquilina Gabriele; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of vitamin B2 (riboflavin and riboflavin 5'-phosphate ester monosodium salt) produced by Bacillus subtilis for all animal species based on a dossier submitted by DSM
    2016
  8. Aquilina Gabriele; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of eight compounds belonging to chemical group 31 (aliphatic and aromatic hydrocarbons) when used as flavourings for all animal species and categories
    2016
  9. Aquilina Gabriele; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of benzoic acid as a feed additive for pigs for fattening when used as acidity regulator and all animal species when used as flavouring
    2016
  10. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of pyridine and pyrrole derivatives belonging to chemical group 28 when used as flavourings for all animal species
    2016
  11. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of manganese compounds (E5) as feed additives for all animal species: manganous carbonate; manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, monohydrate; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate, based on a dossier submitted by FEFANA asbl
    2016
  12. Aquilina Gabriele; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of guanidinoacetic acid for chickens for fattening, breeder hens and roosters, and pigs
    2016
  13. Aquilina Gabriele; Azimonti Giovanna; Bampidis Vasileios; Ramos Maria de Lourdes da Silva; Bories Georges; Chesson A.; Cocconcelli Pier Sandro; Flachowsky Gerhard; Gropp Jürgen M.; Kolar Boris; Kouba Maryline; Puento Secundino López; López-Alonso Marta; Mantovani Alberto; Mayo Baltasar; Ramos Fernando; Rychen Guido; Saarela Maria; Villa Roberto Edoardo; Wallace John Robert; Wester Pieter
    Safety and efficacy of ethyl ester of beta-apo-8'-carotenoic acid as a feed additive for poultry for fattening and poultry for laying
    2016
  14. Gaur Niharika; Karouzakis Emmanuel; Glück Selene; Bagdonas Edvardas; Jüngel Astrid; Michel Beat A.; Gay Renate E.; Gay Steffen; Frank Bertoncelj Mojca; Neidhart Michel
    MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts
    2016
  15. Naji Franjo; Nedog Viljemka; Vokač Damijan; Šuran David; Kanič Vojko; Granda Samo; Šabovič Mišo
    Homocysteine levels in patients with atrial fibrillation after successful electrical cardioversion
    2009
  16. Plazar Nadja; Ostanek Barbara
    Primerjava alelnih frekvenc mutacij ključnih encimov presnove homocisteina med vzorci Slovencev in drugih narodov
    [Allele frequency of mutations of homocysteine metabolism key enzymes in Slovene population in comparison to that in other populations]
    2008
  17. Plazar Nadja; Jurdana Mihaela; Pišot Rado
    Vpliv 35 dnevnega mirovanja na koncentracijo homocisteina v krvi
    [The effect of 35-day bed rest on plasma homocysteine concentration]
    2008
  18. Zaletel Marjan; Ambrožič Aleš; Gašperšič Nataša; Zupan Matija; Žvan Bojana
    Succecssful treatment of brain ischemia with supplementation therapy in a patient with hyperhomocystenemia
    [Uspješno lječenje moždane ishemije dodacima hrani u bolesnice s hiperhomocisteinemijom]
    2011
  19. Jurdana Mihaela; Pišot Rado; Plazar Nadja
    The influence of simulated weightlessness on plasma homocysteine concentration
    2009
  20. Naji Husam Franjo; Šuran David; Kanič Vojko; Vokač Damijan; Šabovič Mišo
    High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion
    2010
  21. Božič-Mijovski Mojca
    Hyperhomocysteinemia and thrombophilia
    2010
  22. Pečovnik-Balon Breda; Knehtl Maša; Bevc Sebastjan; Jakopin Eva; Gorenjak Maksimiljan
    Fetuin-A as a risk factor for mortality in hemodialysis patients
    2010
  23. Plazar Nadja; Jurdana Mihaela
    Hyperhomocysteinemia and the role of B vitamins in cancer
    [Hiperhomocisteinemija in vloga B vitaminov pri raku]
    2010
  24. Ratkajec Tihomir; Bilban Marjan; Starc Radovan
    Influence of psychosocial work-related factors on conventional risk factors of ischemic heart disease and homocysteine in Slovenian male workers
    2008
  25. Blinc A; Poredoš P
    Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    2007
  26. Bevc S; Hojs R; Ekart R; Hojs-Fabjan T
    Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors
    2006
  27. Marčun-Varda Nataša
    Vloga nekaterih genetskih dejavnikov pri nastanku esencialne arterijske hipertenzije pri otrocih in mladih odraslih
    2006
  28. Šebeštjen Miran; Šabovič Mišo; Eržen Barbara; Simčič Saša; Žegura Branka; Poredoš Pavel; Keber Irena
    Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history od myocardial infarction
    2007
  29. Dvoršak Benjamin
    Hiperhomocisteinemija pri bolnikih, ki se zaradi končne ledvične odpovedi zdravijo s hemodializo
    2006
  30. Žemva Aleš
    Motnje v presnovi homocisteina povečujejo srčno-žilno tveganje
    2006
  31. Gregorič Nadan; Fišer Gabrijel
    Polimorfizem v genu za metilentetrahidrofolat reduktazo (MTHFR C677T) - povezava z vensko trombozo in hiperhomocisteinemijo
    2005
  32. Kariž Stojan
    Laboratorijske preiskave pri bolniku s stabilno angino pektoris
    2006
  33. Benca Maja; Žemva Aleš; Skitek Milan; Snoj Nada
    The influence of homocysteine on cardiovascular system - how much do we know? - a study on healthy young adult sibilings of patients with premature cardiovascular disease
    2005
  34. Bevc Sebastjan
    Ateroskleroza pri hemodializnih bolnikih - tradicionalni in netradicionalni dejavniki tveganja
    2005
  35. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  36. Rogel Polona; Žemva Aleš
    Homocistein - dejavnik tveganja za srčno-žilne bolezni
    [Homocysteine - cardiovascular risk factor]
    2005
  37. Benca Maja
    Pomen homocisteina pri potomcih oseb s klinično manifestno aterosklerozo
    2004
  38. Anžej Saša
    Motnje strjevanja krvi pri mladih bolnikih z ishemičnim možganskim dogodkom
    2004
  39. Plazar Nadja; Stegnar Mojca; Rešek-Žužek Saša; Lukač-Bajalo Jana
    Hiperhomocisteinemija pri dializnih bolnikih
    [Hypercysteinemia in hemodialysis patients]
    2004
  40. Šebeštjen Miran; Keber Irena; Žegura Branka; Simčič Saša; Božič Mojca; Migaud-Fressart Martine; Stegnar Mojca
    Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors
    2004
  41. Pečovnik-Balon Breda
    Periferna arterijska bolezen in ledvice
    [Peripheral artery disease and the kidney]
    2004
  42. Dvoršak Benjamin; Hojs Radovan
    Hiperhomocisteinemija pri hemodializnih bolnikih
    [Hyperhomocysteinemia in hemodialysis patients]
    2004
  43. Hojs Radovan; Ekart Robert; Dvoršak Benjamin
    Srčnožilne bolezni in kronična ledvična odpoved
    [Cardiovascular disease and chronic renal failure]
    2004
  44. Ocepek Andreja; Skok Pavel
    Recidivne venske tromboze pri bolnici z ulceroznim kolitisom
    [Recurrent venous thrombosis in a patient with ulcerative colitis]
    2003
  45. Žitnik Lidija; Tetičkovič Erih
    Laboratorijska diagnostika pri mlajših bolnikih z možganskožilnimi boleznimi - redkejši dejavniki tveganja
    2003
  46. Mlakar Uroš
    Sodobni pristopi prepoznavanja megaloblastnih anemij
    2003
  47. Božič Mojca
    Laboratorijski vidiki venske tromboze: dejavniki tveganja, prepoznavanje in spremljanje zdravljenja
    [Laboratory aspects of venous thrombosis: risk factors, identification and therapy monitoring]
    2003
  48. Meglič Leon; Stegnar Mojca; Milanez Tomaž; Božič Mojca; Peterlin Borut; Peternel Polona; Novak-Antolič Živa
    Factor V Leiden, prothrombin 20210G -> A, methylenetetrahydrofolate reductase 677C -> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism
    2003
  49. Osredkar Joško
    Stopenjska laboratorijska diagnostika kardiovaskularnih bolezni
    [Stes in laboratory diagnostic of cardiovascular diseases]
    2003
  50. Šabovič Mišo
    Značilnosti periferne arterijske okluzivne bolezni pri bolnikih s končno ledvično odpovedjo
    [Characterstics of peripheral arterial occlusive disease in patients with end-stage renal disease]
    2003
  51. Hojs Radovan; Ekart Robert; Hojs-Fabjan Tanja
    Ateroskleroza in kronična ledvična odpoved
    [Atherosclerosis and chronic renal failure]
    2003
  52. Kozak Matija
    Homocistein in periferna arterijska bolezen
    [Homocysteine and peripheral artery disease]
    2003
  53. Ekart Robert; Hojs Radovan; Hojs-Fabjan Tanja; Pečovnik-Balon Breda; Dvoršak Benjamin
    Srčnožilne bolezni in kronična ledvična odpoved
    [Cardiovascular disease and chronic renal failure]
    2003
  54. Pajek Jernej
    Homocistein v nefrologiji
    2003
  55. Jerin Aleš
    Metode za določanje homocisteina
    [Methods for the determination of homocysteine]
    2002
  56. Setnikar Nataša; Skitek Milan
    Določanje homocisteina v serumu pri hemodializnih bolnikih s končno odpovedjo ledvic
    [Determination of serum homocysteine in hemodialysis patients in end-stage renal disease]
    2002
  57. Pajek Jernej; Kaplan-Pavlovčič Staša
    Homocistein v nefrologiji
    [Homocysteine in nephrology]
    2002
  58. Skitek Milan
    Homocistein v luči novih spoznanj
    [Homocystein in the spotlight of the new conceptions]
    2002
  59. Osredkar Joško
    Kardiovaskularna obolenja - laboratorijska diagnostika
    [Cardiovascular diseases - laboratory diagnostics]
    2002
  60. Skitek Milan
    Beseda gostujočega urednika
    2002
  61. Kozak Matija
    Zdravljenje hiperhomocistinemije pri bolnikih s kardiovaskularnimi boleznimi
    [Treatment of hyperhomocysteinemia in patients with cardiovascular diseases]
    2002
  62. Stegnar Mojca
    Hiperhomocisteinemija in žilna bolezen
    [Hyperhomocysteinemia and vascular disease]
    2002
  63. Božič Mojca
    Kaj je homocistein?
    [What is homocysteine?]
    2002
  64. Hojs Radovan; Gorenjak Maksimiljan; Ekart Robert; Dvoršak Benjamin; Pečovnik-Balon Breda
    Homocysteine and vascular access thrombosis in hemodialysis patients
    2002
  65. Šebeštjen Miran; Žegura Branka; Keber Irena
    Statins and the assessment of endothelial function - reply to Lee et al
    2002
  66. Niederland T; Gal V; Szoke M; Hollo Z
    Plasma homocysteine, and B12, and folic acid level in hyperinsulinaemic non-diabetic children with mutations in the methylenetetrahydrofolate reductase gene
    2001
  67. Dalla-Volta Sergio; Anzulović-Mirošević Dinko
    Endothelial dysfunction in heart failure
    2001
  68. Žemva Aleš
    Homocysteine - a new marker of cardiovascular risk
    2001
  69. Bertina R
    Identification of molecular risk markers for thrombosis
    2001
  70. Kanič V; Lobnik A
    Homocysteine as risk factor for coronary artery disease for younger people
    2001
  71. Vokač Damijan
    Dejavniki tveganja za aterosklerozo
    [Risk factors for atherosclerosis]
    2001
  72. Božič Mojca; Skitek Milan; Ritonja Anka; Jerin Aleš; Stegnar Mojca
    Določanje celokupnega plazemskega homocisteina
    [Determination of total plasma homocysteine]
    2001
  73. Božič Mojca; Stegnar Mojca; Fermo Isabella; Ritonja Anka; Peternel Polona; Stare Janez; D'Angelo Armando
    Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
    2000
  74. Tesovnik M; Bizjak-Rotovnik A; Jeram D; Skitek M
    Določanje homocisteina v serumu in plazmi
    [Serum and plasma homocysteine levels determination]
    2000
  75. Mlakar Uroš
    Diagnostika pomanjkanja vitamina B12 in folatov
    [Diagnosis of vitamin B12 and folate deficiency]
    2000
  76. Dvoršak B; Hojs R
    Hyperhomocysteinemia in hemodialysis patients
    2000
  77. Žužek-Rešek Saša; Plazar Nadja
    Nivo homocisteina pri bolnikih na nadomestnem zdravljenju
    2000
  78. Dvoršak Benjamin; Hojs Radovan
    Hiperhomocisteinemija pri hemodializnih bolnikih
    [Hyperhomocysteinemia in hemodialysis patients]
    2000
  79. Meglič Leon
    Genetski dejavniki tveganja pri venski trombozi v nosečnosti in puerperiju
    2000
  80. Peternel Polona
    Dejavniki tveganja za nastanek venske tromboze
    [Risk factors for the development of venous thrombosis]
    2000
  81. Hojs R; Gorenjak M; Ekart R; Dvoršak B; Pečovnik-Balon B
    Homocysteine and vascular access thrombosis in hemodialysis patients
    1999
  82. Boič M; Fermo I; Ritonja A; D'Angelo A; Peternel P; Stegnar M
    Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
    1998
  83. Stegnar M; Božič M; Fermo I; Ritonja A; D'Angelo A; Peternel P
    Association of mild hyperhomocysteinemia with fibrinolysis and resistance to activated protein C in venous thromboembolism
    1998
  84. Pavlin Rudi
    Homocistein in ateroskleroza
    [Homocysteine and atherosclerosis]
    1999
  85. Božič M; Meglič L; Stegnar M; Novak-Antolič Ž
    Hyperhomocysteinemia in pregnancy-associated venous thrombo-embolic disease
    1999
  86. Jerše Marjan
    Arterioskleroza, ateroskleroza
    1998
  87. Stegnar Mojca; Božič Mojca
    Pomen homocisteina pri razvoju žilnih bolezni
    [The role of homocysteine in the development of vascular disease]
    1998
  88. Božič Mojca
    Določanje homocisteina in pojavljanje hiperhomocisteinemije pri bolnikih z vensko trombembolijsko boleznijo
    [Homocysteine determination and prevalence of hyperhomocysteinemia in patients with thromboembolic disease]
    1998
  89. Božič M; Fermo I; Ritonja A; D'Angelo A; Peternel P; Stegnar M
    Hyperhomocysteinemia and resistance to activated protein C in patients with history of venous thromboembolism
    1998
  90. Jesenovec N; Kusturin M
    Dokazivanje cistina i homocistina u urinu
    1988


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko